Drug Type Small molecule drug |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Cerevance, Inc.Startup |
Active Organization- |
Inactive Organization Cerevance, Inc.Startup |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Parkinson Disease | Preclinical | US | Cerevance, Inc.Startup | 30 Jan 2022 |